RecruitingNot ApplicableNCT06104904

Managing Anxiety in Pediatric Primary Care (MAPP)

Enhancing the Capacity of Pediatric Primary Care Providers: a Pilot Trial of Anxiety Action Plan


Sponsor

UConn Health

Enrollment

60 participants

Start Date

Nov 20, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to conduct a randomized controlled trial to enhance the capacity of pediatric primary care providers to assist their patients who struggle with anxiety. The study aims to refine and assess the feasibility of the Anxiety Action Plan (AxAP), a brief intervention to reduce pediatric anxiety, delivered by primary care providers (PCPs) in community pediatric primary care clinics. The goal of the AxAP is to enhance the capacity of PCPs to identify and intervene with anxious youth, which will enhance access to care in general and especially in locations with few mental health specialists. PCPs participating in this study will attend a training, administer the intervention to enrolled youth assigned to the MAPP condition, participate in coaching sessions, and fill out study questionnaires. Families participating in this study will complete evaluations with the study team, receive the intervention from their PCP (if assigned to the MAPP condition), and fill out study questionnaires. Researchers will compare the MAPP intervention to Enhanced Usual Care (EUC; consisting of videos, handouts, and other resources for anxiety reduction) to see the differences, if any, in child outcomes.


Eligibility

Min Age: 6 YearsMax Age: 17 Years

Inclusion Criteria2

  • years of age
  • Have elevated anxiety symptoms as indicated by a total Screen for Child Anxiety Rated Disorders score between 20 and 55 based on parent and/or child report

Exclusion Criteria2

  • Have a medical or psychiatric condition contraindicating participation (e.g., suicidality) based on clinical interview
  • Are receiving psychosocial mental health treatment for anxiety

Interventions

BEHAVIORALMAPP

Behavioral intervention based on exposure therapy strategies.


Locations(1)

UConn Health

West Hartford, Connecticut, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06104904


Related Trials